FDA panels set for three compounds

FDA's advisory committees will meet this fall to discuss applications from Acorda Therapeutics Inc. (NASDAQ:ACOR), Purdue Pharma L.P. (Stamford, Conn.) and Schering-Plough Corp. (NYSE:SGP). On Sept. 24, a joint meeting of FDA's Anesthetic and Life Support Drugs and Drug Safety and Risk Management advisory committees will meet to discuss Purdue's NDA for extended-release OxyContin oxycodone to manage moderate to severe pain. ...